For Healthcare Professionals

Mitochondrial Dysfunction in Autism Spectrum Disorder

clipboard-pencil

About the study

Researchers at Arkansas Children's Hospital Research Institute are conducting a study about mitochondrial function in children. The study involves up to 5 visits to Arkansas Children's Hospital with fasting blood draws, behavioral assessments, and/or questionnaires. This study is not currently recruiting, but continues to follow those who were enrolled. There is no cost for visits or study-related exams. For further information, please contact the program manager, Leanna Delhey, at ldelhey@uams.edu or 501-364-4519
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion Criteria:


Inclusion Criteria for ASD children


1. Autism Spectrum Disorder (As defined by a gold standard measure for ASD diagnosis: the Autism Diagnostic Observation Schedule, Autism Diagnostic Interview, and/or the minimum Arkansas state requirement for autism classification, as defined by a consensus diagnosis of ASD by a medical doctor, speech pathologist, and psychologist.). In an event where sufficient diagnostic information is lacking, and the PI believes that the clients meet all other inclusion criteria and a prospective diagnosis of an ASD is clinically warranted, and a formal diagnosis is scheduled to occur within a reasonable time frame from the date of study entry, then the client may be considered as potentially eligible.


  • 0 years through 17 years 11 months of age

  • Inclusion Criteria for TD children


    1. 0 years to 17 years 11 months of age


    EXCLUSION CRITERIA

    Exclusion Criteria:


    * Discussed on a case by case basis


    pin location

    Study Locations

    Enter your ZIP code/Postal code/PIN code to locate study sites near you:

    How to Apply


    Contact the study center to learn if this study is a good match for you.

    Study’s details


    Contition

    Autism Spectrum Disorder,Autism,Mitochondrial Disease,Developmental Delay

    Age (in years)

    < 17

    Participants needed

    297

    Est. Completion Date

    Dec 31, 2025

    Treatment type

    OBSERVATIONAL


    Sponsor

    University of Arkansas

    ClinicalTrials.gov identifier

    NCT02000284

    Study number

    137-162

    Understanding Clinical Trials


    Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
    Vector

    Interested?

    Sign up to save your favorites, 
    receive newsletters, resources, and alerts 
    about clinical trials related to your conditions of interest.